In ALD&NAFLD patients, the PNPLA3 148M allele was associated with younger age, shorter history of cirrhosis, less advanced (Child A) cirrhosis at HCC diagnosis, and lower HCC differentiation grade (p<0.05). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.